These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

284 related articles for article (PubMed ID: 23978412)

  • 1. Coprophilous fungi: antibiotic discovery and functions in an underexplored arena of microbial defensive mutualism.
    Bills GF; Gloer JB; An Z
    Curr Opin Microbiol; 2013 Oct; 16(5):549-65. PubMed ID: 23978412
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dung-inhabiting fungi: a potential reservoir of novel secondary metabolites for the control of plant pathogens.
    Sarrocco S
    Pest Manag Sci; 2016 Apr; 72(4):643-52. PubMed ID: 26662623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mixed fermentation for natural product drug discovery.
    Pettit RK
    Appl Microbiol Biotechnol; 2009 May; 83(1):19-25. PubMed ID: 19305992
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Future potential for anti-infectives from bacteria - how to exploit biodiversity and genomic potential.
    Müller R; Wink J
    Int J Med Microbiol; 2014 Jan; 304(1):3-13. PubMed ID: 24119567
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Creation of a drug-sensitive reporter strain of Pseudomonas aeruginosa as a tool for the rapid screening of antimicrobial products.
    Engelberg R; Danielson A; Wang S; Singh M; Wai A; Sorensen J; Duan K; Hausner G; Kumar A
    J Microbiol Methods; 2018 Sep; 152():1-6. PubMed ID: 30017996
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Anserinones A and B: new antifungal and antibacterial benzoquinones from the coprophilous fungus Podospora anserina.
    Wang H; Gloer KB; Gloer JB; Scott JA; Malloch D
    J Nat Prod; 1997 Jun; 60(6):629-31. PubMed ID: 9214737
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antibiotics from neglected bacterial sources.
    Pidot SJ; Coyne S; Kloss F; Hertweck C
    Int J Med Microbiol; 2014 Jan; 304(1):14-22. PubMed ID: 24120363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The search for new sporicidal agents for medical use: where are we?
    Piktel E; Pogoda K; Savage PB; Bucki R
    Future Microbiol; 2017 Jul; 12():735-737. PubMed ID: 28593804
    [No Abstract]   [Full Text] [Related]  

  • 9. Alternative natural sources for a new generation of antibacterial agents.
    Taylor PW
    Int J Antimicrob Agents; 2013 Sep; 42(3):195-201. PubMed ID: 23796893
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Genomic mining--a concept for the discovery of new bioactive natural products.
    Gross H
    Curr Opin Drug Discov Devel; 2009 Mar; 12(2):207-19. PubMed ID: 19333866
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The search for new anti-infective drugs: untapped resources and strategies.
    Bierbaum G; Sahl HG
    Int J Med Microbiol; 2014 Jan; 304(1):1-2. PubMed ID: 24183099
    [No Abstract]   [Full Text] [Related]  

  • 12. Evolution of multicopper oxidase genes in coprophilous and non-coprophilous members of the order sordariales.
    Pöggeler S
    Curr Genomics; 2011 Apr; 12(2):95-103. PubMed ID: 21966247
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Secondary metabolites from higher fungi: discovery, bioactivity, and bioproduction.
    Zhong JJ; Xiao JH
    Adv Biochem Eng Biotechnol; 2009; 113():79-150. PubMed ID: 19475376
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Metabolite induction via microorganism co-culture: a potential way to enhance chemical diversity for drug discovery.
    Bertrand S; Bohni N; Schnee S; Schumpp O; Gindro K; Wolfender JL
    Biotechnol Adv; 2014 Nov; 32(6):1180-204. PubMed ID: 24651031
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Synthetic biology toward microbial secondary metabolites and pharmaceuticals].
    Wu LZ; Hong B
    Yao Xue Xue Bao; 2013 Feb; 48(2):155-60. PubMed ID: 23672010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The re-emergence of natural products for drug discovery in the genomics era.
    Harvey AL; Edrada-Ebel R; Quinn RJ
    Nat Rev Drug Discov; 2015 Feb; 14(2):111-29. PubMed ID: 25614221
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Confronting the challenges of natural product-based antifungal discovery.
    Roemer T; Xu D; Singh SB; Parish CA; Harris G; Wang H; Davies JE; Bills GF
    Chem Biol; 2011 Feb; 18(2):148-64. PubMed ID: 21338914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antibiotics from Gram-negative bacteria: a comprehensive overview and selected biosynthetic highlights.
    Masschelein J; Jenner M; Challis GL
    Nat Prod Rep; 2017 Jul; 34(7):712-783. PubMed ID: 28650032
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Natural resins and bioactive natural products thereof as potential antimicrobial agents.
    Termentzi A; Fokialakis N; Skaltsounis AL
    Curr Pharm Des; 2011; 17(13):1267-90. PubMed ID: 21470116
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Effect of the Crude Extract of Coprophilous Fungi on Some Bacterial Species Isolated from Cases of Mastitis.
    Jasim AS; Abass BA; Al-Rubayae IM
    Arch Razi Inst; 2021 Nov; 76(5):1333-1341. PubMed ID: 35355757
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.